Issue 4 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

28

No.

4

January 25, 2002Jan 25, 2002

Free

DOWNLOAD THE PDF

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

Venter Steps Down As Celera President; Moffitt, Puerto Rico Center Win NCI P20 Grant.

Susan Sieber, Former NCI Communications Chief, Dead.

Andrew von Eschenbach Sworn In As NCI Director.

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

FDA Approves Abbott’s HER-2 DNA Probe Kit.

Univ. Of Pittsburgh Plans Molecular Medicine Institute.

Recent Issues

Volume 52 | Issue 05 - February 06, 2026

Volume 52 | Issue 04 - January 30, 2026

Volume 52 | Issue 03 - January 23, 2026

Volume 52 | Issue 02 - January 16, 2026

Volume 52 | Issue 1 - January 09, 2026

Volume 51 | Issue 46 - December 19, 2025